Treatment of Subarachnoid Hemorrhage With Human Albumin (ALISAH)
Sponsor: Baylor College of Medicine
Terminated
The study met the pre-specified criteria for stopping the trial
Other terminated trials from Baylor College of Medicine
Other Subarachnoid Hemorrhage trials with similar outcome
A PHASE1 clinical study on Subarachnoid Hemorrhage, this trial is terminated or withdrawn. The trial is conducted by Baylor College of Medicine and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1
First recorded
Jun 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor College of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .